TickerFactsScreenerDevelopers

IGC Pharma, Inc. (IGC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$2.63M2012: -$5.02M2013: $564.8K2014: -$1.74M2015: -$2.58M2016: -$157.7K2017: -$1.39M2018: -$1.93M2019: -$3.33M2020: -$8.68M2021: -$10.80M2022: -$7.46M2023: -$7.05M2024: -$5.20M2025: -$4.79M-$4.79M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$4.79M+7.8%
2024-$5.20M+26.2%
2023-$7.05M+5.6%
2022-$7.46M+30.9%
2021-$10.80M-24.5%
2020-$8.68M-160.6%
2019-$3.33M-72.4%
2018-$1.93M-38.8%
2017-$1.39M-782.1%
2016-$157.7K+93.9%
2015-$2.58M-48.3%
2014-$1.74M-408.4%
2013$564.8K+111.2%
2012-$5.02M-90.6%
2011-$2.63M—